Trinity ELITE | Orthofix Medical | Cancellous bone containing viable cells and demineralised bone | ≥ 500000 cells/mL, of which > 100000 cells/mL are osteogenic cells | ≥ 70% |
Vivigen | DePuy Synthes | Corticocancellous chips containing lineage-committed bone cells and demineralised bone particulate | > 16000 cells/mL | 96% |
Cellentra | Zimmer-Biomet | Cancellous bone containing viable cells and demineralised cortical bone | ≥ 250000 cells/mL in the cancellous tissue | ≥ 70% |
Osteocel Pro | NuVasive | Cryopreserved viable cancellous matrix and ground demineralised bone matrix | Average of 3 million cells/mL | > 85% on average |
Bio4 | Stryker | A cryopreserved viable bone matrix product that contains native matrix, endogenous osteoblasts and mesenchymal stem cells, and osteoinductive and angiogenic growth factors | On average, ≥ 600000 cells/mL | ≥ 70% |
Map3 | RTI Surgical | Cortical cancellous bone chips, demineralised bone matrix and multipotent adult progenitor cell-class cells | ≥ 50000 viable cells/mL of implant | Not available |
Allostem | Allosource | Allogenic adult adipose-derived mesenchymal stem cells combined with partially demineralised allograft bone. | 66255 viable cells/mL | Not available |